EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 85 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,155,318 | +21.2% | 1,145,847 | +32.0% | 0.00% | 0.0% |
| Q2 2023 | $7,551,278 | +177.5% | 867,963 | -6.2% | 0.00% | +100.0% |
| Q1 2023 | $2,721,311 | +35.5% | 925,616 | +61.3% | 0.00% | – |
| Q4 2022 | $2,008,608 | -44.7% | 573,888 | +24.9% | 0.00% | -100.0% |
| Q3 2022 | $3,633,000 | -56.4% | 459,372 | -56.6% | 0.00% | -50.0% |
| Q2 2022 | $8,335,000 | -54.3% | 1,059,117 | -29.5% | 0.00% | -50.0% |
| Q1 2022 | $18,241,000 | -3.0% | 1,501,296 | -2.3% | 0.00% | 0.0% |
| Q4 2021 | $18,799,000 | +81.2% | 1,535,913 | +54.3% | 0.00% | +100.0% |
| Q3 2021 | $10,372,000 | +10.9% | 995,324 | -4.3% | 0.00% | 0.0% |
| Q2 2021 | $9,349,000 | -17.5% | 1,039,785 | -6.8% | 0.00% | -33.3% |
| Q1 2021 | $11,337,000 | +12358.2% | 1,115,804 | +7940.7% | 0.00% | – |
| Q4 2020 | $91,000 | – | 13,877 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $50,920,000 | 12.31% |
| ACUTA CAPITAL PARTNERS, LLC | 307,944 | $3,742,000 | 1.75% |
| Samsara BioCapital, LLC | 480,000 | $5,832,000 | 1.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,909,407 | $35,349,000 | 1.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,666 | $2,256,000 | 0.93% |
| Altium Capital Management LP | 224,541 | $2,728,000 | 0.91% |
| RA Capital Management | 3,370,506 | $40,952,000 | 0.89% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 276,591 | $3,361,000 | 0.42% |
| MYDA Advisors LLC | 55,000 | $668,000 | 0.26% |
| Atom Investors LP | 40,855 | $496,000 | 0.23% |